← All stocks

Antero Midstream Corp

AM Net selling
CIK 0001623925 #901 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$5.26M
$2.19M on a plan · $0.00 straight out of an exercise
Sold at will
$3.07M
7 of 8 sales
Net
−$5.26M
−$3.07M against sales at will

By person

14 insiders · 8 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kennedy Michael N.
See Remarks
$2.19M (1) scheduled
−$2.19M
1,500,594
0.3161%
$31.92M
+24.1%
Schultz Yvette K
See Remarks
$2.09M (2)
−$2.09M
580,565
0.1223%
$12.35M
+24.3%
Pearce Sheri
See Remarks
$670.80K (2)
−$670.80K
83,900
0.0177%
$1.78M
−35.6%
KLIMLEY BROOKS J
Director
$310.10K (3)
−$310.10K
68,204
0.0144%
$1.45M
−16.6%
RADY PAUL M
See Remarks
3,074,200
0.6476%
$65.39M
+13.3%
Krueger Brendan E.
See Remarks
674,952
0.1422%
$14.36M
+42.9%
Agnew Justin J.
See Remarks
208,895
0.0440%
$4.44M
+8.9%
Keenan W Howard JR
Director
157,691
0.0332%
$3.35M
+11.6%
KEYTE DAVID H
Director
117,903
0.0248%
$2.51M
+22.4%
MOLLENKOPF JOHN C
Director
106,566
0.0225%
$2.27M
+18.2%
MCARDLE JANINE J
Director
82,424
0.0174%
$1.75M
+27.1%
DEA PETER A
Director
68,808
0.0145%
$1.46M
−17.3%
Chisholm Nancy
Director
34,208
0.0072%
$727.60K
+92.2%
Munoz Jeffrey S.
Director
13,404
0.0028%
$285.10K
Insider
Date
Role
Action
Shares
Price
Amount
KLIMLEY BROOKS J
6 Aug 2026
Director
Sell
5,000
$21.27
$106.35K
Pearce Sheri
4 Aug 2026
See Remarks
Sell
16,000
$22.01
$352.16K
Kennedy Michael N.
4 May 2026
See Remarks
Sold on a plan
100,000
$21.92
$2.19M
Schultz Yvette K
4 May 2026
See Remarks
Sell
69,269
$21.90
$1.52M
KLIMLEY BROOKS J
12 Mar 2026
Director
Sell
5,000
$23.16
$115.80K
Pearce Sheri
10 Mar 2026
See Remarks
Sell
14,000
$22.76
$318.64K
Schultz Yvette K
9 Mar 2026
See Remarks
Sell
25,000
$22.81
$570.25K
KLIMLEY BROOKS J
16 Dec 2025
Director
Sell
5,000
$17.59
$87.95K

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 1,504,329
History held since 9 May 2017